Position
Marex Group plc in Spruce Biosciences, Inc.
Back to the book · All holders of SPRB
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.92K$0.42 → $0.29
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q2 2024 | 14.8K | $7.66K | — | — | — | 0.0% |
| Q3 2024 | 14.8K | $7.03K | $0.47 | −$633 | −$0 | 0.0% |
| Q4 2024 | 14.8K | $6.22K | $0.42 | −$813 | $0 | 0.0% |
| Q1 2025 | 14.8K | $4.29K | $0.29 | −$1.92K | −$0 | 0.0% |